DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION; LTD.;DAEWOONG PHARMACEUTICAL CO., LTD.;DAEWOONG PHARMACEUTICAL CO.
发明人:
OH, Sung-Yong,MIN, Kyung-Hyun
申请号：
PH12016501733
公开号：
PH12016501733A1
申请日:
2016.09.02
申请国别(地区):
PH
年份:
2017
代理人:
摘要：
The present invention provides a pharmaceutical composition for preventing or treating skin rash comprising epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.
